• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Anorexia: An Update for the Psychopharmacologist
Clinical Update

Anorexia: An Update for the Psychopharmacologist

January 31, 2023
Chris Aiken, MD and Garrett Rossi, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Garrett Rossi, MD. Adult psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Dr. Aiken and Dr. Rossi have no financial relationships with companies related to this material.

Anorexia nervosa is notoriously difficult to treat. While psychotherapy is the treatment of choice, medications can play a role, and in this article, we’ll take a look at some options—including a mineral that often gets overlooked: zinc.

Antipsychotics

Antipsychotics seem like an intuitive choice for anorexia given their potential to increase weight and appetite. However, the clinical trials of antipsychotics—which date back to the early 1960s—have not yielded favorable results. Olanzapine, risperidone, and amisulpride did not bring about significant improvements in BMI or body image scores in a meta-analysis of eight small randomized controlled trials (RCTs) (Lebow J et al, Int J Eat Disord 2013;46(4):332–339).

Antidepressants

Antidepressants met a similar fate. In the 1980s, four small randomized controlled trials found little benefit with tricyclics. Anorexia also raises the risks of arrhythmias on tricyclics, so they are best avoided in these patients. The SSRIs did not fare any better. Studies of both fluoxetine and citalopram failed to provide a meaningful benefit over placebo.

Cyproheptadine

The results look more positive with cyproheptadine, an antihistamine whose pharmacodynamic profile resembles the antidepressant mirtazapine. Both cyproheptadine and mirtazapine block histamine and serotonin-2 receptors, improving sleep while causing similar side effects of fatigue and weight gain. Both are used in medical conditions that lower appetite, but only cyproheptadine has studies in anorexia (Halmi KA et al, Arch Gen Psychiatry 1986;43(2):177–181).

In two separate RCTs, researchers randomized hospitalized patients with anorexia to receive cyproheptadine, amitriptyline, or placebo (total n = 111). Cyproheptadine improved weight gain and depressive symptoms after one to three months, but only in patients without bulimic features (target dose 8 mg QID, starting at 2 mg TID and titrated over three weeks).

Dronabinol

Another novel approach is dronabinol, a synthetic cannabinoid that the FDA has approved for weight loss in HIV/AIDS. This medication lacks RCTs in anorexia but was superior to placebo in terms of weight gain in one small crossover study (Andries A et al, Int J Eating Disord 2014;47(1):18–23).

Zinc

Zinc levels are often low in patients with anorexia due to inadequate intake, and this deficiency creates a vicious cycle by lowering appetite even further. One RCT tested a daily 100 mg dose of zinc in 35 females with anorexia in the inpatient setting. The rate of increase in BMI for the zinc group was twice that of the placebo group (Birmingham CL et al, Int J Eat Disord 1994;15(3):251–255). Although zinc is available over the counter, adherence seems to improve when it is written as a prescription. The typical dose is zinc gluconate 100 mg daily. The studies reported no adverse effects from zinc ­supplementation.

Psychotherapy

Psychotherapy is the mainstay of treatment for anorexia, and there are several effective options to guide patients toward. Cognitive behavioral therapy (CBT), focal psychodynamic therapy, and interpersonal therapy are more successful in adults, and certain types of family therapies have better outcomes in adolescents. Family therapies go by an array of names (eg, systemic family therapy, family-based treatment, the Maudsley model), but they all have one thing in common. They don’t scrutinize family dynamics to find the root cause of the problem. Instead, they empower parents to refeed their child. Later, they work on family dynamics or adolescent development as weight is restored.

On average, patients gain about 1.5 lbs a week with inpatient psychotherapy and 0.25–0.5 lb a week with outpatient psychotherapy. Mild cases may recover within six months of therapy, while it may take a year or more to restore weight in patients with severe anorexia (Zeeck A et al, Front Psychiatry 2018;9:158).

Nutritional counseling is helpful and sometimes necessary. A dietician can suggest meal plans and supplements and clarify caloric requirements and nutritional deficiencies for the patient and clinical team. Patients participating in CBT nutritional counseling can also assist with self-monitoring of dietary patterns and identifying and avoiding cues to restrict, binge, or purge.

CARLAT VERDICT 

In anorexia, focus on guiding the patient to an effective psychotherapy and an appropriate level of care. Zinc supplementation and cyproheptadine may be beneficial, but pharmacologic options are few and the evidence supporting them is very preliminary. 

General Psychiatry Clinical Update
KEYWORDS anorexia nervosa Eating disorders medical comorbidities psychosomatics
    Aiken eic 150x150
    Chris Aiken, MD

    AI in Practice

    More from this author
    Garrett Rossi, MD.

    A Psychedelic Primer

    More from this author
    www.thecarlatreport.com
    Issue Date: February 1, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Grief, TCPR, February 2023
    Anorexia: An Update for the Psychopharmacologist
    Prolonged Grief Disorder
    The Medical Evaluation of Anorexia
    Top Augmentation Strategies for Treatment-Resistant Depression?
    CME Post-Test, Grief, TCPR, February 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2635946985.jpg
      General Psychiatry

      AI in Practice

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.